Corrigendum to "Amygdalin in antineoplastic medicine and the relevance of nanotechnology" [Biomed. Pharmacother. 182 (2025) 117772]

Biomed Pharmacother. 2025 Jul:188:118176. doi: 10.1016/j.biopha.2025.118176. Epub 2025 May 23.

Authors

Queenie Fernandes¹, Nashiru Billa²

Affiliations

¹ Translational Cancer Research Facility, National Centre for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.
² Pharmaceutical Sciences Department, College of Pharmacy, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar. Electronic address: nbilla@qu.edu.qa.

PMID: 40413119
DOI: 10.1016/j.biopha.2025.118176

No abstract available

Publication types

Published Erratum